{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:02:44Z","timestamp":1791129764118,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1684\/bdc.2011.1397","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T19:58:33Z","timestamp":1565726313000},"page":"779-795","source":"Crossref","is-referenced-by-count":14,"title":["Nouveau syst\u00e8me de score pour le diagnostic des pr\u00e9dispositions aux cancers du sein et de l\u2019ovaire associ\u00e9es \u00e0 BRCA1\/2"],"prefix":"10.1016","volume":"98","author":[{"given":"Bernard","family":"Bona\u00efti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Alarcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Bonadona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Pennec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Andrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Stoppa-Lyonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Perdry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bona\u00efti-Pelli\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2011.1397_bib0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.respe.2008.03.117","article-title":"Cancer incidence and mortality in France over the period 1980-2005","volume":"56","author":"Belot","year":"2008","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1684\/bdc.2011.1397_bib0010","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM199705153362002","article-title":"BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer","volume":"336","author":"Couch","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2011.1397_bib0015","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jama.1997.03550150046034","article-title":"BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing","volume":"278","author":"Shattuck-Eidens","year":"1997","journal-title":"JAMA"},{"key":"10.1684\/bdc.2011.1397_bib0020","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","article-title":"Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals","volume":"20","author":"Frank","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1397_bib0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/sj.bjc.6600008","article-title":"A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes","volume":"86","author":"Antoniou","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1684\/bdc.2011.1397_bib0030","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/sj.bjc.6602175","article-title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancer","volume":"91","author":"Antoniou","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1684\/bdc.2011.1397_bib0035","series-title":"Risques h\u00e9r\u00e9ditaires de cancers du sein et de l\u2019ovaire : quelle prise en charge ?","year":"1998"},{"key":"10.1684\/bdc.2011.1397_bib0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jnci\/89.3.227","article-title":"Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history","volume":"89","author":"Berry","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1684\/bdc.2011.1397_bib0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2","volume":"62","author":"Parmigiani","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1684\/bdc.2011.1397_bib0050","first-page":"219","article-title":"Identification et prise en charge des pr\u00e9dispositions h\u00e9r\u00e9ditaires aux cancers du sein et de l\u2019ovaire (mise \u00e0 jour 2004)","volume":"91","author":"Eisinger","year":"2004","journal-title":"Bull Cancer"},{"key":"10.1684\/bdc.2011.1397_bib0055","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/jmg.2003.017996","article-title":"A new scoring system for the chances of identifying a BRCA1\/2 mutation outperforms existing models including BRCAPRO","volume":"41","author":"Evans","year":"2004","journal-title":"J Med Genet"},{"key":"10.1684\/bdc.2011.1397_bib0060","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1136\/jmg.2005.031989","article-title":"Update on the Manchester Scoring System for BRCA1 and BRCA2 testing","volume":"42","author":"Evans","year":"2005","journal-title":"J Med Genet"},{"key":"10.1684\/bdc.2011.1397_bib0065","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2007.056556","article-title":"Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics","volume":"45","author":"Antoniou","year":"2008","journal-title":"J Med Genet"},{"key":"10.1684\/bdc.2011.1397_bib0070","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.2003.07.007","article-title":"Application of breast cancer risk prediction models in clinical practice","volume":"21","author":"Domchek","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1397_bib0075","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/sj.bjc.6603358","article-title":"Evaluation of models to predict BRCA germline mutations","volume":"95","author":"Kang","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1684\/bdc.2011.1397_bib0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jmg.2006.044388","article-title":"Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer","volume":"44","author":"Simard","year":"2007","journal-title":"J Med Genet"},{"key":"10.1684\/bdc.2011.1397_bib0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10689-009-9305-1","article-title":"Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1\/2 mutation detection","volume":"9","author":"van Harssel","year":"2010","journal-title":"Fam Cancer"},{"key":"10.1684\/bdc.2011.1397_bib0090","first-page":"875","article-title":"Oncog\u00e9n\u00e9tique : estimation des besoins de la population en France pour les 10 ans \u00e0 venir","volume":"96","author":"Bonaiti-Pellie","year":"2009","journal-title":"Bull Cancer"},{"key":"10.1684\/bdc.2011.1397_bib0095","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/jmg.2009.067850","article-title":"Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing","volume":"46","author":"Evans","year":"2009","journal-title":"J Med Genet"},{"key":"10.1684\/bdc.2011.1397_bib0100","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.ejca.2007.04.023","article-title":"Genetic epidemiology of BRCA mutations \u2013 family history detects less than 50% of the mutation carriers","volume":"43","author":"M\u00f8ller","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1684\/bdc.2011.1397_bib0105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1200\/JCO.2009.25.0712","article-title":"Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women","volume":"28","author":"Metcalfe","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1397_bib0110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ygyno.2007.09.035","article-title":"High frequency of BRCA1\/2 germline mutations in consecutive ovarian cancer patients in Poland","volume":"108","author":"Brozek","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1684\/bdc.2011.1397_bib0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/GIM.0b013e318032e4ab","article-title":"Prediction of BRCA1\/2 mutation status in patients with ovarian cancer from a hospital-based cohort","volume":"9","author":"Jacobi","year":"2007","journal-title":"Genet Med"},{"key":"10.1684\/bdc.2011.1397_bib0120","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1086\/302853","article-title":"BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer","volume":"66","author":"Moslehi","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1684\/bdc.2011.1397_bib0125","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"key":"10.1684\/bdc.2011.1397_bib0130","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1684\/bdc.2011.1397_bib0135","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1200\/JCO.2008.16.6231","article-title":"Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer","volume":"26","author":"Atchley","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1397_bib0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cancergencyto.2008.11.003","article-title":"Histopathological criteria and selection algorithms for BRCA1 genetic testing","volume":"189","author":"Gadzicki","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1684\/bdc.2011.1397_bib0145","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1200\/JCO.2006.06.5664","article-title":"Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer","volume":"24","author":"Haffty","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1397_bib0150","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1471-2407-8-100","article-title":"Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers","volume":"8","author":"Litwiniuk","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1684\/bdc.2011.1397_bib0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2407-9-86","article-title":"The prevalence of BRCA1 mutations among young women with triple-negative breast cancer","volume":"9","author":"Young","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1684\/bdc.2011.1397_bib0160","first-page":"805","article-title":"Why are the majority of hereditary cases of early-onset breast cancer sporadic? A simulation study","volume":"9","author":"Cui","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1684\/bdc.2011.1397_bib0165","series-title":"Estimation de l\u2019incidence des cancers en France 1983-1987","author":"de Vathaire","year":"1996"},{"key":"10.1684\/bdc.2011.1397_bib0170","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada","volume":"98","author":"Risch","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1684\/bdc.2011.1397_bib0175","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1684\/bdc.2011.1397_bib0180","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1397_bib0185","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/jnci\/djm203","article-title":"Breast cancer risk among male BRCA1 and BRCA2 mutation carriers","volume":"99","author":"Tai","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1684\/bdc.2011.1397_bib0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2307\/1534657","article-title":"La place des familles \u00e0 quatre g\u00e9n\u00e9rations en France","volume":"51","author":"Pennec","year":"1996","journal-title":"Population"},{"key":"10.1684\/bdc.2011.1397_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3917\/popsoc.374.0001","article-title":"Combien d\u2019enfants, combien de fr\u00e8res et s\u0153urs depuis cent ans ?","volume":"374","author":"Toulemon","year":"2001","journal-title":"Population et Soci\u00e9t\u00e9s"},{"key":"10.1684\/bdc.2011.1397_bib0200","unstructured":"Bona\u00efti B, Alarcon F, Bonadona V et al. A new scoring system in cancer genetics: application to the identification of BRCA1\/2 mutations (en pr\u00e9paration)."},{"key":"10.1684\/bdc.2011.1397_bib0205","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3917\/popu.803.0437","article-title":"L\u2019\u00e9volution d\u00e9mographique en France : l\u2019esp\u00e9rance de vie progresse toujours","volume":"63","author":"Prioux","year":"2008","journal-title":"Population"},{"key":"10.1684\/bdc.2011.1397_bib0210","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jmg.2004.028829","article-title":"Cancer risks in BRCA2 families: estimates for sites other than breast and ovary","volume":"42","author":"van Asperen","year":"2005","journal-title":"J Med Genet"},{"key":"10.1684\/bdc.2011.1397_bib0215","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1159\/000152448","article-title":"A general model for the genetic analysis of pedigree data","volume":"21","author":"Elston","year":"1971","journal-title":"Hum Hered"},{"key":"10.1684\/bdc.2011.1397_bib0220","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/gepi.20390","article-title":"PEL: an unbiased method for estimating age-dependent genetic disease risk from pedigree data unselected for family history","volume":"33","author":"Alarcon","year":"2009","journal-title":"Genet Epidemiol"},{"key":"10.1684\/bdc.2011.1397_bib0225","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1200\/JCO.2010.28.0719","article-title":"Expanding the criteria for BRCA mutation testing in breast cancer survivors","volume":"28","author":"Kwon","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115306123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115306123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T23:58:28Z","timestamp":1721606308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115306123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0007455115306123"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2011.1397","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}